Docetaxel 75 mg/m(2) is active and well tolerated in patients with metastatic or recurrent gastric cancer: a phase II trial (Q44153194)
Jump to navigation
Jump to search
scientific article published in July 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Docetaxel 75 mg/m(2) is active and well tolerated in patients with metastatic or recurrent gastric cancer: a phase II trial |
scientific article published in July 2002 |
Statements
1 reference
Docetaxel 75 mg/m(2) is active and well tolerated in patients with metastatic or recurrent gastric cancer: a phase II trial (English)
1 reference
Yung-Jue Bang
1 reference
Won Ki Kang
1 reference
Yoon-Koo Kang
1 reference
Hugh Chul Kim
1 reference
Christian Jacques
1 reference
Emmanuel Zuber
1 reference
Byzance Daglish
1 reference
Yvane Boudraa
1 reference
Won Seog Kim
1 reference
Dae Seog Heo
1 reference
Noe Kyeong Kim
1 reference
1 July 2002
1 reference
1 reference
32
1 reference
7
1 reference
248-254
1 reference
Identifiers
1 reference
1 reference